Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Slow-acting anti-rheumatic agents: recent developments].

Daniel Van Linthoudt1, Jean-Charles Gerster

  • 1Services de Rhumatologie, Médecine physique et Réhabilitation. Daniel.VanLinthoudt@ne.ch

Revue Medicale De La Suisse Romande
|November 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial.

Arthritis research & therapy·2014
Same author

Pathogenic role of basic calcium phosphate crystals in destructive arthropathies.

PloS one·2013
Same author

Acute heel pain related to apatite deposition in the plantar fascia.

Joint bone spine·2012
Same author

[What is your diagnosis?].

Praxis·2010
Same author

[The humeroradial impingement].

Praxis·2010
Same author

[Clinical presentation imaging and treatment of digital osteoarthritis].

Revue medicale suisse·2010

Osteoarthritis treatments are evolving beyond symptom management to disease modification. Emerging therapies, including chondroitin sulfate and glucosamine sulfate, show potential for cartilage repair and slowing disease progression.

Area of Science:

  • Orthopedics
  • Rheumatology
  • Biochemistry

Context:

  • Osteoarthritis (OA) treatment traditionally focused on managing joint pain and disability.
  • Conventional OA therapies include analgesics, anti-inflammatory drugs, steroid injections, and physical therapy.
  • Recent research highlights the growing importance of disease-modifying osteoarthritis drugs (DMOADs).

Purpose:

  • To review current and emerging therapeutic strategies for osteoarthritis.
  • To explore the role of slow-acting substances in modifying OA disease progression.
  • To discuss the potential of basic matricial precursors and novel pathways in OA management.

Summary:

  • Current OA management primarily addresses symptoms, but disease-modifying approaches are gaining traction.

Related Experiment Videos

  • Substances like chondroitin sulfate, glucosamine sulfate, and hyaluronic acid may reduce cartilage destruction and promote chondrocyte activity.
  • These precursors show promise in slowing joint space narrowing, suggesting a structural impact on cartilage.
  • Further research using advanced imaging and biomarkers is needed to confirm these effects.

    • Impact:

    • This research informs the development of novel OA therapies targeting disease mechanisms.
    • Findings suggest a shift towards treatments that can positively influence OA's long-term evolution.
    • Understanding OA's complex pathophysiology, including cytokine roles, opens avenues for combination therapies.